Rakshit Drugs Private Limited

Rakshit Drugs Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24230TG2000PTC034018 Incorporated 24 March 2000 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2024
₹256.13 Cr
▼ 3% YoY
Net profit · FY 2024
₹5.47 Cr
Net margin 2.1%
EBITDA · FY 2024
₹18.34 Cr
EBITDA margin 7.2%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.24 Cr
Issued & subscribed
Open charges
₹60.73 Cr
Satisfied ₹20.29 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
34
Provident fund records

About Rakshit Drugs Private Limited

Data last updated:

Rakshit Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 24 March 2000 and has been in existence for over 26 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2000PTC034018. Its GSTIN is 36AABCR5942G1ZC (Telangana). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.24 Cr. It is led by directors including Anjaneya Pattabhi Rameswara Rao Chandana (Managing Director) and Rajeshkumar Joshi (Managing Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2024, the company reported a revenue of ₹256.13 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹5.47 Cr (net margin 2.1%) and EBITDA of ₹18.34 Cr (EBITDA margin 7.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 4% over five years.

The company has about 34 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Rakshit Drugs. As per MCA filings, the company has open charges of ₹60.73 Cr and satisfied charges of ₹20.29 Cr on record. Court records list 15 cases involving the company, including 11 filed by the company and 4 filed against it; 1 case is pending.

Rakshit Drugs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0022546). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rakshitdrugspvtltd.com.

Company details

CIN U24230TG2000PTC034018
Registration Number 034018
Incorporation Date 24 March 2000
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0022546

CIN history

Rakshit Drugs has one previous CIN (Corporate Identification Number): U24230AP2000PTC034018. The current CIN is U24230TG2000PTC034018, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230TG2000PTC034018Current
U24230AP2000PTC034018Previous

Recognitions & Rankings of Rakshit Drugs

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-TS-02-0022546

Contact details

Rakshit Drugs Private Limited's registered office is in Hyderabad, Telangana. Its website is rakshitdrugspvtltd.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    P.No 28 4th And 5th Floors, HUDA Techno Enclave Sector – III, Hyderabad, Telangana, India – 500081
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Rakshit Drugs Private Limited, buy the company report.

Comprehensive company report
Rakshit Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Rakshit Drugs operates one associated brand: Rakshit Drugs. Each brand links to its own profile.

BrandDescriptionWebsite
Active pharmaceutical ingredients and intermediates are manufactured globally.rakshitdrugspvtltd.com

Business activity

The main business activity of Rakshit Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Rakshit Drugs Private Limited, buy the company report.

Financials of Rakshit Drugs Private Limited

FY 2025 filings available

Rakshit Drugs Private Limited reported revenue of ₹256.13 Cr (down 3% YoY) for FY 2024.

Revenue · FY 2024
₹256.13 Cr ▼ 3%
Net profit · FY 2024
₹5.47 Cr margin 2.1%
EBITDA · FY 2024
₹18.34 Cr margin 7.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 2%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▲ 24%
3 years · compounded
▼ 19%
5 years · compounded
▲ 1%

Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹18.34 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.47 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin7.2%
Net Profit Margin2.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rakshit Drugs Private Limited, buy the company report.

Board of directors of Rakshit Drugs Private Limited

Rakshit Drugs has 6 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Palem SrinivasDirector07 Jul 200818 Years 3 MonthsCurrent
Anjaneya Pattabhi Rameswara Rao ChandanaManaging Director24 Mar 200026 Years 7 MonthsCurrent
Aruna Kumari ChandanaWhole-Time Director24 Mar 200026 Years 7 MonthsCurrent
Avinash Shoury ChandanaDirector25 Feb 200719 Years 8 MonthsCurrent
Bhavani Sankar AllaWhole-Time Director26 Nov 20241 Years 11 MonthsCurrent
Rajeshkumar JoshiManaging Director07 May 200917 Years 5 MonthsCurrent

Peer comparison

Rakshit Drugs Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sodium Metal Pvt Ltd₹273.32 Cr (FY 2023)-11.0%Vadodara, Gujarat, India
Saraf Chemicals Private Limited₹271.96 Cr (FY 2025)16.0%Mumbai, Maharashtra, India
Venkata Narayana Active Ingredients Private Limited₹271.82 Cr (FY 2025)53.0%Chennai, Tamil Nadu, India
Styrax Pharma Private Limited₹260.24 Cr (FY 2024)4.0%Visakhapatnam, Andhra Pradesh, India
Rakshit Drugs Private Limitedthis company₹256.13 Cr (FY 2024)₹5.47 Cr2.1%-3.0%34Hyderabad, Telangana, India
Shodhana Laboratories Private Limited₹250.16 Cr (FY 2024)-23.0%Hyderabad, Telangana, India
East India Pharmaceutical Works Limited₹249.94 Cr (FY 2024)Kolkata, West Bengal, India
Rakshit Pharmaceuticals Limited₹238.14 Cr (FY 2024)-6.0%Hyderabad, Telangana, India
Century Pharmaceuticals Limited₹234.99 Cr (FY 2025)-1.0%Vadodara, Gujarat, India
Delta Finochem Private Limited₹234.28 Cr (FY 2025)-18.0%Nashik, Maharashtra, India

To see the full peer comparison of Rakshit Drugs Private Limited, buy the company report.

Auditor

Rakshit Drugs Private Limited is audited by Ramanathan & Rao for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Ramanathan & RaoFY 20232934S

Shareholding

The shareholding of Rakshit Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Rakshit Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹60.73 Cr
Satisfied charges
₹20.29 Cr
Breakdown by lending institutions
Others₹60.73 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
01 Feb 200810089028Others₹60.73 CrOpen
28 Mar 2017100086867Sidbi₹90 LakhSatisfied
12 Jun 200910168794Amneal Pharmaceuticals Company (India) Private Limited₹13 CrSatisfied
24 Jul 200810115305Hdfc Bank Limited₹8.75 LakhSatisfied
26 Apr 200280001893Lakshmi Vilas Bank Limited₹6.04 CrSatisfied

To see the full charge records of Rakshit Drugs Private Limited, buy the company report.

Total charge records: 7 View all charges

Credit ratings & regulatory alerts

Rakshit Drugs Private Limited was last rated by Crisil on 27 May 2020.

Rating agencyRated onRating
Crisil27 May 2020

To see the full credit ratings and regulatory alerts of Rakshit Drugs Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rakshit Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Rakshit Drugs has 1 subsidiary company and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
1
Associated companies
Key subsidiaries
Company NameCINShares held
Rakshit Research Centre Private LimitedU24303TG2022PTC159416

To see the full group structure of Rakshit Drugs Private Limited, buy the company report.

Employees & EPFO

Rakshit Drugs Private Limited has a workforce of 34 employees on its EPFO records as of Oct 28, 2024, across 2 active EPFO establishments.

Employee count
34
Active EPFO establishments
2
Employee growth
-20.93%

GST

Rakshit Drugs has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AABCR5942G1ZCTelanganaActive01 Jul 2017
37AABCR5942G2Z9Andhra PradeshActive24 Jul 2018

To see the full GST registrations and return filing status of Rakshit Drugs Private Limited, buy the company report.

Recent activity

Rakshit Drugs Private Limited has 9 board changes on record since 2000: 6 appointments and 3 cessations. The latest: Bhavani Sankar Alla ceased to be Additional Director on 31 Mar 2025.

AGM
Rakshit Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 60.73 Cr registered on 01 Feb 2008 with Charge ID 10089028 was modified on 25 Jul 2025.
Filing
Rakshit Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Bhavani Sankar Alla ceased to be Additional Director.
Appointed
Bhavani Sankar Alla was appointed as Whole-Time Director.
Charges
A charge registered on 28 Mar 2017 via Charge ID 100086867 with Sidbi was fully satisfied on 21 Jan 2021.
Charges
A charge registered on 24 Jul 2008 via Charge ID 10115305 with Hdfc Bank Limited was fully satisfied on 06 Feb 2020.
Charges
A charge with Sidbi amounted to Rs. 0.90 Cr with Charge ID 100086867 was registered on 28 Mar 2017.
Ceased
Aruna Kumari Chandana ceased to be Director.
Ceased
Rajeshkumar Joshi ceased to be Whole-Time Director.
Charges
A charge registered on 12 Jun 2009 via Charge ID 10168794 with Amneal Pharmaceuticals Company (India) Private Limited was fully satisfied on 29 Jul 2010.
Charges
A charge with Amneal Pharmaceuticals Company (India) Private Limited amounted to Rs. 13.00 Cr with Charge ID 10168794 was registered on 12 Jun 2009.

16 earlier events are in the company report.

Frequently asked questions

Rakshit Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 24 March 2000 (26+ years old) and is registered under CIN U24230TG2000PTC034018.

Rakshit Drugs has 6 current directors:

The latest financial statements of Rakshit Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Rakshit Drugs is 36AABCR5942G1ZC, registered in Telangana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 37AABCR5942G2Z9 (Andhra Pradesh).

The CIN (Corporate Identification Number) of Rakshit Drugs is U24230TG2000PTC034018. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rakshit Drugs has 15 court cases on record: 11 filed by the company and 4 filed against it. 1 is pending. Most are in the high courts.

Rakshit Drugs was incorporated on 24 March 2000, making it 26+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Rakshit Drugs by revenue are Sodium Metal Pvt Ltd, Saraf Chemicals Private Limited, Venkata Narayana Active Ingredients Private Limited, Styrax Pharma Private Limited, Shodhana Laboratories Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Bhavani Sankar Alla ceased to be Additional Director on 31 Mar 2025. Bhavani Sankar Alla was appointed as Whole-Time Director on 26 Nov 2024. Aruna Kumari Chandana ceased to be Director on 22 Nov 2014. Rakshit Drugs has 9 board changes on record in total.

Yes, Rakshit Drugs is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0022546).

Rakshit Drugs can be reached through the website rakshitdrugspvtltd.com. Its registered office is in Hyderabad, Telangana, India.